Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response

Annals of Thoracic Surgery

Volumn 63, Issue 1, 1997, Pages 277-284

  Boyle Jr , Edward M ^a   Pohlman, Timothy H ^a   Johnson, Marion C ^a   Verrier, Edward D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SURGERY; ENDOTHELIUM INJURY; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW;

EID: 0342981747     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01061-2     Document Type: Article

References (62)

1. Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg. 51:1991;529-531.
2. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass evidence for generation of C3a and C5a anaphylatoxins . N Engl J Med. 304:1981;497-503.
3. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s systemic inflammatory response and organ dysfunction . JAMA. 271:1994;226-233.
4. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple organ failure syndrome. Arch Surg. 121:1986;196-208.
5. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 70:1990;427-451.
6. Faymonville ME, Pincemail J, Duchateau J, et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg. 102:1991;309-317.
7. Verrier ED, Shen I. Potential role of neutrophil anti-adhesion therapy in myocardial stunning, myocardial infarction, and organ dysfunction after cardiopulmonary bypass. J Cardiol Surg. 8:1993;309-312.
8. Vedder NB, Winn RK, Rice CL, et al. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci USA. 87:1990;2643-2646.
9. Knudsen F, Andersen LW. Immunological aspects of cardiopulmonary bypass. J Cardiothorac Anesth. 4:1990;245-258.
10. Nilsson L, Kulander L, Nystrom SO, Eriksson O. Endotoxins in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 100:1990;777-780.
11. Pohlman TH, Harlan JM. Endotoxin-endothelial Interactions. Morrison DC, Ryan J. Bacterial endotoxic lipopolysacchrides, Vol 1. 1992;348-369 CRC Press, Boca Raton.
12. Crossman DC, Tuddenham EDG. Procoagulant functions of the endothelium. Warren JB. The endothelium an introduction to current research . 1990;119-128 Wiley-Liss, New York.
13. Taggart DP, Sundaram S, McCartney C, et al. Endotoxemia, complement, and white blood cell activation in cardiac surgery a randomized trial of laxatives and pulsatile perfusion . Ann Thorac Surg. 57:1994;376-382.
14. Moat NE, Rebuck N, Shore DF, et al. Humoral and cellular activation in a simulated extracorporeal circuit. Ann Thorac Surg. 56:1993;1509-1514.
15. Wachtfogel YT, Kucich U, Greenplate J, et al. Human neutrophil degranulation during extracorporeal circulation. Blood. 69:1987;324-330.
16. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 106:1993;1008-1016.
17. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 94:1994;1147-1155.
18. Frering B, Philip I, Dehoux M, et al. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 108:1994;636-641.
19. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 56:1993;S92-6.
20. Kalfin RE, Engelman RM, Rousou JA, et al. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation. 88(Suppl 2):1993;401-406.
21. Finn A, Naik S, Klein N, et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 105:1993;234-241.
22. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;552-559.
23. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 108:1994;626-635.
24. Bankey PE, Hill S, Geldon D. Sequential insult enhances liver macrophage-stimulated hepatocyte dysfunction. J Surg Res. 57:1994;185-191.
25. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 90:1992;2333-2339.
26. Verrier ED. The vascular endothelium friend or foe? Ann Thorac Surg. 55:1993;818-819.
27. Virkhaus R, Lucchesi BR, Simpson PJ, Shebuski RJ. The role of adhesion molecules in cardiovascular pharmacology meeting review . J Pharmacol Exp Ther. 273:1995;569-575.
28. Gillinov AM, Redmond JM, Zehr KJ, et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg. 57:1994;126-133.
29. Gillinov AM, Bator JM, Zehr KJ, et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg. 56:1993;847-853.
30. Gillinov AM, Redmond JM, Winkelstein JA, et al. Complement and neutrophil activation during cardiopulmonary bypass a study in the complement-deficient dog . Ann Thorac Surg. 57:1994;345-352.
31. Kilbridge PM, Mayer JE, Newburger JW, et al. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 107:1994;1183-1192.
32. Wilson I, Gillinov AM, Curtis WE, et al. Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation. 88(Suppl 2):1993;372-379.
33. Burns SA, DeGuzman BJ, Newburger JW, et al. P-selectin expression in myocardium of children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 110:1995;924-933.
34. Wilmore DW, Aulick LH, Mason AD, Pruitt BA. Influence of the burn wound on local and systemic responses to injury. Ann Surg. 196:1978;444-458.
35. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA. 83:1986;3460-3464.
36. Montgomery KF, Osborn L, Hession C, et al. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci. 88:1991;6523-6527.
37. Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA. 84:1987;9238-9242.
38. Harlan J. Leukocyte-endothelial interactions. Blood. 65:1985;513-525.
39. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
40. Cho PW, Gillinov AM, Zehr KJ, et al. Neutrophil activation mediates protamine-induced pulmonary hypertension. J Surg Res. 54:1993;486-493.
41. Atkinson JP, Farries T. Separation of self from non-self in the complement system. Immunol Today. 8:1987;212-215.
42. Spiess BD. Introduction. J Cardiovasc Pharmacol. 27:1996;v-vii.
43. Wagner DD. The Weibel-Palade body the storage granule for von Willebrand factor and P-selectin . Thromb Haemost. 70:1993;105-110.
44. Rinder C, Fitch J. Amplification of the inflammatory response adhesion molecules associated with platelet/white cell responses . J Cardiovasc Pharmacol. 27:1996;S6-12.
45. Kilgore KS, Shen JP, Miller BF, et al. Enhancement by complement membrane attack complex of tumor necrosis factor induced endothelial cell expression of E-selectin and ICAM-1. J Immunol. 155:1995;1434-1441.
46. Lorant DE, Topham MK, Whatley RE, et al. Inflammatory roles of P-selectin. J Clin Invest. 92:1993;559-570.
47. Thanos D, Maniatis T. NF-kB a lesson in family values . Cell. 80:1995;529-532.
48. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 8:1992;2581-2590.
49. Magnuson DK, Maier RV, Pohlman TH. Protein kinase C a potential pathway of endothelial cell activation by endotoxin, tumor necrosis factor, and interleukin-1 . Surgery. 106:1989;216-223.
50. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules NF-kB and cytokine-inducible enhancers . FASEB J. 9:1995;899-909.
51. Nilsson L, Tyd'en H, Johansson O, et al. Bubble and membrane oxygenators - comparison of postoperative organ dysfunction with special reference to inflammatory activity. Scand J Thorac Cardiovasc Surg. 24:1990;59-64.
52. Gu YJ, Obster R, Haan J, et al. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate. Artif Organs. 17:1993;660-665.
53. Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 58:1994;472-477.
54. Gu YJ, van-Oeveren W, Akkerman C, et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;917-922.
55. Jones DR, Hill RC, Hollingsed MJ, et al. Use of heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 56:1993;566-568.
56. Wilson IC, Gardner TJ, DiNatale JM, et al. Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion. J Thorac Cardiovasc Surg. 106:1993;805-810.
57. Cameron D. Initiation of white cell activation during cardiopulmonary bypass cytokines and receptors . J Cardiovasc Pharmacol. 27:1996;S1-5.
58. Sharar SR, Winn RK, Murry CE, et al. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits. Surgery. 110:1991;213-219.
59. Hansen T, Dawson P, Brockbank K. Effects of hypothermia upon endothelial cells mechanisms and clinical importance . Cryobiology. 31:1994;101-106.
60. Johnson M, Haddix T, Pohlman T, Verrier ED. Hypothermia reversibly inhibits endothelial cell expression of E-selectin and tissue factor. J Cardiol Surg. 10:1995;428-435.
61. Menasche P, Peynet J, Haeffner-Cavallion N, et al. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. Circulation. 92(Suppl 2):1995;334-340.
62. Le Deist F, Menasche P, Kucharski C, et al. Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion a clinical study . Circulation. 92(Suppl 2):1995;354-358.